10X aligns Wall Street with Silicon Valley, bringing institutional capital to high growth technology ventures which are disrupting trillion dollar markets. 

Our portfolio companies include Robinhood, DraftKings (Nasdaq:DKNG), Shift (Nasdaq:SFT), Palantir (NYSE:PLTR), Wish, Compass Therapeutics, Circle, Ripple, Better, Pipefy, Akash Systems, AlphaFlow and Milo.

10X Capital is the sponsor of the SPAC 10X Capital Venture Acquisition Corp, and has multiple asset management brands including Growth Technology Partners (venture capital), Charleston Capital Management (fintech credit) and 10X Capital Partners (multi-manager long/short equity).

Beyond its direct investment and asset management businesses, 10X Capital operates an investment banking business targeting emerging technology companies seeking access to equity and debt capital markets.

For more information, please visit http://10xcapital.com

Comparably

Senti Biosciences

Inkbox

Compass Therapeutics, Inc.

23andMe

Wish

ZenSports

DraftKings

Grove Collaborative

Skylight

Ubiquity6

Udemy

Usermind

Vicarious

FiscalNote

Osmosis

Palantir Technologies

Presto

Punchh

Reel

10X Capital

🚨🚨 Episode 12 of Liquidity Podcast is out and this week Jason Calacanis and I have Hunter Somerville from StepStone Group and Logan Bartlett from Redpoint Ventures!

In this episode, we dive deep into the world of venture capital including Tiger and A16Z's latest fund announcements!

Link to the episode below 👇

Jason Calacanis is off All-In this week, but you can find him on Liquidity Episode 11 - hot off the press 🔥.  

This week we have legendary investors Tomasz Tunguz of Theory Ventures and David Clark of VenCap.  

What would you like to see on next week's episode? Comment below.

Link to Youtube in comments 👇.

🎙 On today’s episode of the 10X Capital Podcast, Harisha Koneru Haigh from the Northwestern University endowment and I discuss the art of building and managing relationships in venture capital, as well as:

1️⃣ Northwestern's venture and crypto strategies
2️⃣ Common mistakes made by seasoned VCs
3️⃣ The ideal characteristics of a venture manager

Thank you to our sponsor Deel!

Video clip below - Sound on.

Click “+ Follow” by my name to see more clips.

P.S. Link to full episode in comments.
 
#VentureCapital #VC #Startups #OpenLP Turpentine 10X Capital

New Liquidity Pod is out and it's lit 🔥! 

Joining Jason Calacanis and I this week is Mamoon Hamid Managing Partner of Kleiner Perkins and Thomas Scriven Managing Director at the University of Pennsylvania.  Link in comments below 👇

🎙 On today’s episode of the 10X Capital Podcast, StepStone Group Partner Hunter Somerville and I discuss StepStone’s unique approach to venture capital, as well as:

1️⃣ Accessing companies through funds, direct investments, and secondaries
2️⃣ Identifying stand-out emerging managers
3️⃣ StepStone's value-add to funds and companies

Thank you to our sponsor Deel!

Video clip below - Sound on.

Click “+ Follow” by my name to see more clips.

P.S. Link to full episode in comments.
 
#VentureCapital #VC #Startups #OpenLP Turpentine

🔥REVEALED: The Billion-Dollar Return Giants…Some of the companies fuelling outsized VC returns…

🎙️ In a recent interview with Jason Calacanis, David Clark (CIO at Vencap) debunked the narrative that “large VC funds” can’t generate meaningful returns! 

💸 Vencap combed through 36 years of data on the VC funds they’ve backed…

…and identified 50 (!) companies that had returned over $1 BILLION in profits back to a specific fund that backed them! 

📊 The table shows 15 companies that were named by Clark in the interview…

🕵🏻‍♂️I dug into which VCs were invested at the earliest stages into these gargantuan outcomes. 

🔍 Spoiler Alert: It’s not a surprise. 

🎯The usual suspects -- Andreessen Horowitz (A16Z), Index Ventures, Accel, First Round, USV, ICONIQ, Sequoia & LocalGlobe all feature!

🚀 Note that Peter Thiel & Marc Andreessen were very successful angels before starting Founders Fund & A16Z. 

🔥Andreessen invested in the seed round of Slack & Twitter & Thiel invested in the seed of Facebook & Stripe. 

🤯Elon Musk was also an angel in the seed round of $65bn fintech behemoth Stripe. 

(The upper echelons of tech are a small world)

——

💰It’s worth noting that given the outsized outcomes, the later stage (B,C,D+) investors are also very IN THE MONEY!

💼 Vencap now has a concentrated fund strategy backing just 12 different managers (across fund cycles) which include many of those mentioned above.

——

📈 Another eye-catching bit of data on the influence individual companies can have on fund returns came from Atul Rustgi of Fund of Funds Accolade Partners 👇

🎙️On a recent 10X Capital podcast with David Weisburd, he cited that:

➜ In Accolade Fund I: 10 out of ~ 500 underlying companies returned the whole fund! 

➜ In Accolade Fund III: 10 out of ~500 underlying companies returned 3x the whole fund!

🤯Just 2% of companies returned 1-3x of capital invested. 

🕵🏻‍♂️This *extreme* power law dynamic is most pronounced in VC, and is why diversifying (be it at fund or company level is important). 

——

🔑 It’s important for angels, allocators & family offices to appreciate: 

➜ The extreme power law that exists across companies, funds, general partners & fund returns! 

➜ The persistence that exists across funds who are lucky enough to have an early blockbuster (the likelihood of another is markedly higher than the mean)

——

📊What are your thoughts on these statistics ? Which up & coming companies do you think will join this exclusive club?  Drop them in comments. 👇

PS- If you enjoyed this & found it valuable, ♻️ consider sharing it with others & 👉🏽follow me Akhil Paul for more!

🎧 Links to podcasts in comments. 

#startups #venturecapital #entrepreneurship #investing Saul VenCap International plc

Omega Therapeutics is a biotechnology company focused on developing novel therapies for various diseases.

Omega Therapeutics

BioAtla is a biopharmaceutical company specializing in the development of conditionally active biologics (CAB).

BioAtla

LENZ Therapeutics is a pharmaceutical company dedicated to developing novel treatments for various medical conditions.

LENZ Therapeutics

Genfit is a biopharmaceutical company focused on the discovery and development of innovative therapeutic and diagnostic solutions for metabolic and liver-related diseases.

Genfit

Tuatara Capital is a private equity firm specializing in investments in the cannabis industry.

Tuatara Capital

Bregal Partners is a private equity firm that focuses on investing in middle-market companies across various industries.

Bregal Partners

25madison is a venture studio and early-stage venture capital firm that partners with entrepreneurs to build and scale transformative technology companies.

25madison

UcliQ is a B2B marketplace platform that connects retail, restaurants, hotels, and businesses for streamlined procurement processes.

UcliQ

FoodHack is a community-driven platform that connects food entrepreneurs, industry experts, and investors to drive innovation in the food industry.

FoodHack

Ripe Technology is a technology company that provides solutions for the retail and hospitality industries, focusing on enhancing customer experiences and operational efficiency.

Ripe Technology

10X Capital is a venture capital firm that specializes in providing growth equity to technology companies. The firm focuses on partnering with exceptional entrepreneurs and management teams to help scale businesses and create substantial value.

10X Capital Venture Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company intends to focus on identifying technology and tech-enabled businesses in the consumer internet, ecommerce, software, healthcare, transportation/mobility, and financial services industries, as well as other industries that are being disrupted by advances in technology and on technology paradigms, including artificial intelligence automation, data science, ecommerce, and software-as-a-service. 10X Capital Venture Acquisition Corp. II was incorporated in 2021 and is based in New York, New York.

news impact assignment basic	general
public peers	general	Jun 22, 2024 5:44 PM	49c6738d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 8:10 PM	adbbe23f
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 22, 2024 5:44 PM	ba7c9bbd
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 5:44 PM	61bb8cef
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:10XCAPITAL

10X Capital

Last Close

10.56

06/12 21:00

Market Cap

86.39M

Beta: -

Volume Today

104.20K

Avg: -